aod9604 human clinical trials weight loss results The effects of 14 day infusion of saline (control), (250 AOD-9604 – 5mg – Prime

Individual response varies based on factors including metabolic rate, insulin sensitivity, activity level, and previous peptide experience

Key finding: AOD 9604 showed superior lipolytic activity (EC50 45 nM) versus native GH (EC50 380 nM) with insulin-independent mechanism

AOD-9604 (also catalogued as hGH Fragment 176191 or Tyr-hGH 177191) is a 16-amino-acid synthetic peptide derived from the C-terminal region of human growth hormone

Safety data from over 900 clinical trial participants demonstrates that AOD-9604 is remarkably well-tolerated with a side effect profile indistinguishable from placebo in most studies

A pattern of 12 weeks on, 4-6 weeks break, repeated several times, produces sustainable results without the receptor desensitization that can occur with extremely long continuous use